Skip to main content
OpenTrials
Completed

NCT Number: NCT03379285

Management of Digestive Haemorrhaging In CHRU of Brest During 2009 and 2014

Gastro intestinal (GI) bleeding is relatively frequent and may lead to intensive care unit admission. Although a restrictive strategy for red blood cell transfusion is supported by a large randomized controlled trial literature, less is known about the impact of transfusion strategy of other blood components and administration of anti fibrinolytic on clinical outcomes.

This study aims to identify parameters that may be associated with the risk of further bleeding in patients admitted to ICU for GI bleeding.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gastro Intestinal Bleeding Digestive System Diseases Gastrointestinal Diseases Gastrointestinal Hemorrhage Hemorrhage Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest

Brest, 29609, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Gastro Intestinal Bleeding admitted to either medical or surgical intensive care unit

Exclusion criteria

  • patients retrieved from another hospital
  • age < 18 years consent withdrawal

Treatment and study plan

Primary outcomes

  1. Bleeding

    Time frame: within a week

    Bleeding persistance or recidive requiring an intervention or a scope

Secondary outcomes

  1. mortality

    Time frame: during hospitalisation (28 days)

    hospital mortality

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Risk Factors for Further Bleeding in Patients Admitted to Intensive Care for Gastro Intestinal Bleeding

Acronym: HDréa

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Dec 20, 2017
Registry last updated
Dec 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.